Peloton Therapeutics
Latest round
- Series E
Last raised
- Feb 2019
Total raised
- $214M
Investors
- 14
About Peloton Therapeutics
Peloton Therapeutics, Inc.Founded in 2010 and headquartered in Dallas, US, Peloton Therapeutics, Inc. specializes in developing drugs that target HIF-2a, a crucial factor in certain cancers. The company has not undergone any reported changes in its operations and does not have any known subsidiaries.15 billion.Peloton Therapeutics, Inc. focuses on developing pharmaceutical products aimed at treating cancer, particularly renal cell carcinoma and von Hippel-Lindau (VHL) disease. Their primary candidates target and modulate HIF-2a activity, addressing significant unmet medical needs in oncology.Peloton Therapeutics operates under a revenue model that relies on partnerships and collaborations within the pharmaceutical industry. Revenue is generated through milestone payments from collaborations with larger pharmaceutical firms and potential royalty agreements upon successful product commercialization. The company prioritizes structured agreements with healthcare organizations and research institutions, ensuring ongoing investment in clinical trials to validate its drug candidates.Peloton Therapeutics is focused on expanding its portfolio of products aimed at treating serious health conditions, particularly cancer therapies centered around HIF-2a. The company is also looking to broaden its market reach internationally, although specific regions and timelines for expansion have not been disclosed.
Who invested in Peloton Therapeutics
14 investors across 5 rounds
See all investors in Peloton Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Peloton Therapeutics
Who invested in Peloton Therapeutics?
Peloton Therapeutics has 14 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Peloton Therapeutics raised?
Peloton Therapeutics has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Peloton Therapeutics last raise money?
Peloton Therapeutics's most recent round on record is a Series E, in Feb 2019.
What does Peloton Therapeutics do?
Peloton Therapeutics is a biotechnology company.
Where is Peloton Therapeutics headquartered?
Peloton Therapeutics is headquartered in Dallas, US.
Which VCs invest in companies like Peloton Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Peloton Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Peloton Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.